HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Unilever/Phytera

This article was originally published in The Rose Sheet

Executive Summary

Companies enter research agreement for the development of new personal care products, Phytera says. Under the deal, the biotech company will provide its ExPAND plant cell extracts and uMARINE microorganisms, which Unilever will screen to determine their appropriate use. The deal is the first for Phytera in the personal care arena; the Worchester, Mass.-based company entered into similar collaborations in the pharmaceutical industry with partners like Eli Lilly and Chiron

Latest Headlines
See All
UsernamePublicRestriction

Register

RS007690

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel